Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.

导出原文传递

翻译打印收藏纠错

作者： Anouk,Rijken ^[1] ; Checca,Bakkers ^[2] ; Heinz-Josef,Klümpen ^[3] ; Lydia G,van der Geest ^[4] ; Judith,de Vos-Geelen ^[5] ; Felice N,van Erning ^[1] ; Ignace H J T,de Hingh ^[6]

作者单位： Department of Surgery, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands. ^[1] Department of Surgery, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, the Netherlands. ^[2] Department of Medical Oncology, Amsterdam University Medical Center, University of Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. ^[3] Department of Research and Development, Netherlands Comprehensive Cancer Organization, Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands. ^[4] Department of Internal Medicine, Division of Medical Oncology, Maastricht UMC+, P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands; GROW, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands. ^[5] Department of Surgery, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands; GROW, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands. Electronic address: ignace.d.hingh@catharinaziekenhuis.nl. ^[6]

关键词 Biliary tract cancer Hepatocellular carcinoma Incidence Peritoneal metastases Risk factors Survival Treatment